An Open Label, 4-Week, Randomised, Multi-Centre, Phase IV Study to Compare the Efficacy and Safety of Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder.
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Quetiapine (Primary) ; Lithium
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Acronyms MANIA
- Sponsors AstraZeneca
- 22 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.